Languages Client Login

News archive for April 2013

All of our news from April 2013

The Patent Box - Fixed price, maximum benefit

April 2013

From 1 April 2013, the "patent box" will reduce the rate of UK corporation tax on qualifying profits from patented products to 10%. We can provide a fixed-price patent filing programme for new products to take advantage of these tax benefits.
Find out more

Updates — In this section

All latest updates

Webinar: Attracting Big Pharma to the Microbiome Field
July 2020
HGF Partners Craig Thomson and Dr Andrew Wells will be presenting a webinar on 'Attracting Big Pharma to the Microbiome Field' on 8th July.
Read More
Coronavirus update - HGF offices
July 2020
This page provides information on any HGF office closures that may happen as a result of Corona virus safety measures in Europe and the UK.
Read More
The European Patent Institute (epi) Webinar series - “Case Law Online“
July 2020
HGF Partner Leythem Wall will be presenting a webinar on “Priority” on 1st July and on “Clarity” on 8th July.
Read More
UK Supreme Court invalidates Regeneron’s transgenic mouse patents for lack of sufficiency
June 2020
In its long-awaited judgment on the dispute over patents for transgenic mice, the UK Supreme Court has held by a majority (Lady Black dissenting) that Regeneron’s patents are invalid for a lack of sufficiency (Regeneron Pharmaceuticals Inc (Respondent) v Kymab Ltd (Appellant) [2020] UKSC 27).
Read More
COVID-19 licensing challenges
June 2020
The taking of new therapies and technologies forward to meet the challenges of COVID-19 is happening at previously unprecedented rates. MHRA is taking flexible approaches to regulation during the COVID-19 outbreak. This includes providing expedited scientific advice, and rapid reviews of clinical trials applications.
Read More